Viking Therapeutics Inc (VKTX)
81.93
-1.41
(-1.69%)
USD |
NASDAQ |
Mar 28, 16:00
81.90
-0.03
(-0.04%)
Pre-Market: 20:00
Viking Therapeutics Cash from Investing (TTM): -179.09M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -179.09M |
September 30, 2023 | -207.56M |
June 30, 2023 | -168.13M |
March 31, 2023 | 55.33M |
December 31, 2022 | 54.75M |
September 30, 2022 | 74.90M |
June 30, 2022 | 61.63M |
March 31, 2022 | 46.21M |
December 31, 2021 | 37.96M |
September 30, 2021 | 40.82M |
June 30, 2021 | 17.57M |
March 31, 2021 | 23.79M |
December 31, 2020 | 41.57M |
September 30, 2020 | 0.237M |
June 30, 2020 | 25.02M |
March 31, 2020 | 26.22M |
December 31, 2019 | 7.463M |
Date | Value |
---|---|
September 30, 2019 | -123.87M |
June 30, 2019 | -166.11M |
March 31, 2019 | -243.71M |
December 31, 2018 | -265.73M |
September 30, 2018 | -127.73M |
June 30, 2018 | -99.26M |
March 31, 2018 | -33.40M |
December 31, 2017 | -1.73M |
September 30, 2017 | 4.113M |
June 30, 2017 | 3.162M |
March 31, 2017 | -0.9039M |
December 31, 2016 | 3.030M |
September 30, 2016 | 3.538M |
June 30, 2016 | -0.1545M |
March 31, 2016 | -7.497M |
December 31, 2015 | -13.47M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-243.71M
Minimum
Mar 2019
74.90M
Maximum
Sep 2022
-28.75M
Average
24.41M
Median
Cash from Investing (TTM) Benchmarks
Eli Lilly and Co | -7.153B |
Pfizer Inc | -32.28B |
Madrigal Pharmaceuticals Inc | -502.52M |
Akero Therapeutics Inc | -223.62M |
89bio Inc | -123.02M |